Home › NDC Lookup › RxCUI directory › RxCUI 849503

Desmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP] — RxCUI 849503

RxNorm drug concept · Semantic branded drug
RxCUI 849503 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI849503
Official nameDesmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDDAVP 4 MCG/ML Injectable Solution; DDAVP 0.004 MG/ML Injectable Solution
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Desmopressin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. It replaces the hormone that helps your body hold on to water in central diabetes insipidus. Some forms also treat hemophilia A and von Willebrand’s dise...
  • Desmopressin makes your body hold on to water. Drinking too much can dilute the sodium in your blood, which can be dangerous. Ask your prescriber exactly how much fluid is right fo...
  • Why do I need to limit how much I drink?
  • Headache, nausea, stomach cramps, and flushing are possible. Nasal forms can cause a stuffy or runny nose or nosebleeds. Call right away for severe headache, confusion, vomiting, q...
📖 Read our full Desmopressin guide →

🕸️ Concept Web — How Desmopressin acetate 0.004 MG/ML Injectable Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Desmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP] RxCUI 849503

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Desmopressin 3251
    • Desmopressin acetate 42634
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • DDAVP 203658
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Desmopressin Injectable Solution 371714
    • Desmopressin acetate Injectable Solution 2647470
    • Desmopressin Injectable Product 1157760
    • Desmopressin acetate Injectable Product 2662298
    • Desmopressin Injectable Solution [DDAVP] 92301
    • Desmopressin acetate Injectable Solution [DDAVP] 2654662
    • DDAVP Injectable Product 1166306
    • Injectable Solution 316949
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Desmopressin acetate 0.004 MG/ML Injectable Solution SCD · 849501
  • Desmopressin acetate 0.004 MG/ML SCDC · 849500
  • Desmopressin Injectable Solution SCDF · 371714
  • Desmopressin acetate Injectable Solution SCDFP · 2647470
  • Desmopressin Injectable Product SCDG · 1157760
  • Desmopressin acetate Injectable Product SCDGP · 2662298

Brand-Name Concepts

  • Desmopressin acetate 0.004 MG/ML [DDAVP] SBDC · 849502
  • Desmopressin Injectable Solution [DDAVP] SBDF · 92301
  • Desmopressin acetate Injectable Solution [DDAVP] SBDFP · 2654662
  • DDAVP Injectable Product SBDG · 1166306
  • DDAVP BN · 203658

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 849503 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55566-2200-00 10 AMPULE in 1 CARTON (55566-2200-0) / 1 mL in 1 AMPULE DDAVP Ferring Pharmaceuticals Inc. 1984-05-01
55566-2300-00 1 VIAL, MULTI-DOSE in 1 CARTON (55566-2300-0) / 10 mL in 1... DDAVP Ferring Pharmaceuticals Inc. 1984-05-01
Observed labelers: Ferring Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2597 Inj desmopressin acetate 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.